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A putative transcriptional regulator of the AraC/XylS family was identified in a
genomic genebank of Bacteroides fragilis Bf-1, which partially relieved the
sensitivity of Escherichia coli DNA repair mutants to the DNA-damaging agents,
metronidazole and mitomycin C. A homologue of this gene with the same
phenotype was identified as BF638R3281 in B. fragilis 638R. Transcription of
BF638R3281 was constitutive with respect to exposure to sublethal doses of
metronidazole. BF638R3281 was interrupted by single cross-over gene-specific
insertion mutation, and the gene disruption was confirmed by PCR and DNA-
sequencing analysis. The mutant grew more slowly than the wild type, and the
mutation rendered B. fragilis more sensitive to metronidazole and mitomycin
C. This indicates that the BF638R3281 gene product plays a role in the survival of
B. fragilis following DNA damage by these agents.
Introduction
Bacteroides species are Gram-negative obligate anaerobes
residing in the gastrointestinal tract of mammals, and
accounting for approximately one-third of the colonic
microbiota (Salyers, 1984). Bacteroides fragilis is a medically
important opportunistic pathogen, causing more than 80%
of anaerobic infections including abscess formation and
septicaemia. One of the drugs of choice in treating B. fragilis
infections is metronidazole, and the level of resistance is
currently o 5% worldwide (Falagas & Siakavellas, 2000).
However, there are indications that this is increasing, and a
small number of clinical isolates are resistant to metronida-
zole and other therapeutic agents simultaneously (Turner
et al., 1995).
Metronidazole enters cells as an inactive prodrug and is
activated intracellularly via anaerobic reduction to form the
reactive intermediate, which is a DNA-damaging agent
(Edwards, 1977). The mechanisms of resistance to metroni-
dazole described thus far in Bacteroides include active drug
efflux (Pumbwe et al., 2006), the presence of nim genes that
code for drug-inactivating nitroreductases (Löfmark et al.,
2005), as well as alteration of electron flux by modulation of
pyruvate breakdown (Narikawa et al., 1991; Diniz et al.,
2004; Gal & Brazier, 2004).
Studies have shown that impairment of DNA repair
mechanisms caused increased sensitivity of bacteria to
metronidazole, whereas overproduction of the recA gene
from a plasmid caused increased resistance to the drug
(Chang et al., 1997). Escherichia coli recA and nucleotide
excision repair mutants are more sensitive to metronidazole
than the wild-type isogenic strain (Jackson et al., 1984;
Yeung et al., 1984), as are recA mutants of Bacteroides
thetaiotaomicron, Helicobacter pylori and Mycobacterium
bovis (Thompson & Blaser, 1995; Cooper et al., 1997; Sander
et al., 2001). The elucidation of the DNA repair response of
Bacteroides to metronidazole exposure could provide valu-
able information regarding the potential alternative me-
chanisms of resistance or susceptibility of the bacteria to
metronidazole.
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In the present study, a twofold approach was used to
identify candidate genes involved in the cellular response of
B. fragilis to metronidazole and mitomycin C (MTC)
damage. A genomic B. fragilis genebank was screened in a
suitable drug-sensitive DNA repair mutant E. coli host for a
candidate gene conferring resistance. The gene of interest
was then specifically mutated in B. fragilis, by insertional
inactivation, to determine its functional role in the cell
response to DNA damage. Here, the isolation and character-
ization of a putative transcriptional regulator that increased
the resistance of E. coli DNA repair mutants to metronida-
zole and MTC is reported, and it is shown that this regulator
was also required for wild-type cell responses to these DNA-
damaging agents in B. fragilis.
Materials and methods
Bacterial strains and plasmids
The plasmids and strains used in this study are described in
Table 1. Genbank analysis and primer extension experiments
were performed with DNA and RNA derived from
B. fragilis Bf-1 (Mossie et al., 1979). All subsequent experi-
ments were performed with B. fragilis 638R (Privitera et al.,
1979), because B. fragilis Bf-1 cannot be manipulated
genetically. Bacteroides fragilis strains were grown at 37 1C
in supplemented brain heart infusion (BHIS) medium
(Holdeman & Moore, 1972) in an anaerobic chamber
(Model 1024, Forma Scientific Inc., Marietta, OH) contain-
ing an atmosphere of oxygen-free N2, CO2 and H2 (85 : 10 : 5
by volume). Escherichia coli strains were grown aerobically at
37 1C on Luria–Bertani (LB) broth or agar (1.5% w/v)
medium (Sambrook et al., 1989) with the addition of
ampicillin (100mg mL1) where applicable.
Isolation of a plasmid conferring resistance to
DNA-damaging agents
Plasmid pAN2 harbouring 4.5 kb of B. fragilis Bf-1 chromo-
somal DNA was isolated from a gene bank (Southern et al.,
1986) by screening on Luria agar, containing ampicillin and
MTC (range 0.6–1 mg mL1). This plasmid, or control plas-
mid pMT104, was transformed into the relevant E. coli DNA
repair mutant strains and analysed for increased resistance
to DNA-damaging agents.
Plasmid constructions
Localization of the functional region of pAN2 was deter-
mined by subcloning and deletion analysis. Deletion plas-
mids pANBB, pANC and pANH (Fig. 1) were constructed
by subcloning the 2.5-kb HindIII–BglII fragment, the 1.4-kb
HindIII–PvuII fragment and the 1.9-kb HindIII–BamHI
fragment from pAN2, respectively, into pEcoR251. Plasmids
pRecQ and pE2Reg were constructed by cloning the ampli-
fied 2300 and 900-bp fragments from pAN2 into pEcoR251,
using primer pairs 1 and 2, respectively (Table 2).
Metronidazole and MTC resistance assays in E.
coli repair mutants
The agar dilution method was used for drug resistance
assays. For aerobic growth, stationary-phase cultures of
E. coli strains AB1157, AB1886, AB1885 and AB1884,
Table 1. Bacterial strains and plasmids
Strains Relevant characteristics Sources or references
B. fragilis Bf-1 Metronidazole and MTC susceptible Mossie et al. (1979)
B. fragilis 638R Metronidazole and MTC susceptible Privitera et al. (1979)
B. fragilis 638R reg Mutant created by insertional inactivation of BF638R3281. This study
E. coli JM109 recA1, D(lac-proAB)[F 0,traD36,proAB,lacIZDM15] Setlow et al. (1963)
E. coli AB1157 uvr1 ATCC29055 Bachmann (1987)
E. coli AB1886 uvrA6, derived from AB1157 Howard-Flanders et al. (1966)
E. coli AB1885 uvrB5, derived from AB1157 Howard-Flanders et al. (1966)
E. coli AB1884 uvrC34, derived from AB1157 Howard-Flanders et al. (1966)
E. coli S17-1 recA derivative of E. coli 294 (F thi pro hsdR) carrying
a modified derivative of IncPa plasmid pRP4 (Aps Tcs Kms)
integrated in the chromosome, Tpr
Simon et al. (1983)
Plasmids
pEcoR251 E. coli suicide vector, Zabeau & Stanley (1982)
pMT104 pEcoR251 with a noncoding insert Wehnert et al. (1990)
pAN2 pEcoR251 with 4.5-kb B. fragilis genomic fragment This work
pGERM Bacteroides insertion vector containing ermG and oriTRK2
that is mobilized by RP4 transfer functions in E. coli S17-1
chromosome; (Emr Rep) Apr
Cheng et al. (2000)
pGAR pGERM-derivative with BF638R3281 internal fragment This work
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containing pAN2 or pMT104, were diluted, and 103 cells
were plated onto LB–ampicillin agar plates containing either
MTC (range 0–2.4 mg mL1) or metronidazole (range
0–1000 mg mL1). For anaerobic growth, the same E. coli
cultures were plated on prereduced yeast–tryptone (YT)
agar, containing the antibiotics, and also supplemented with
0.5% glucose and 0.2% sodium nitrate. The minimum
inhibitory concentration (MIC) was determined after a 24-
h incubation under aerobic or anaerobic conditions.
DNA sequencing and computer analysis
Sequencing reactions were performed using the DYEnamic
ET Dye terminator Cycle sequencing Kit for MegaBACE
(Molecular Dynamics), based on dideoxynucleotide chain
termination chemistry (Sanger et al., 1977). The nucleotide
sequences were analysed using the MEGABACE 500 SEQUENCE
ANALYSER v2.4 software and the software program DNAMAN,
version 4.13 (Lynnon BioSoft). Sequence similarity searches
were performed using the NCBI BLAST program (Altschul
et al., 1997).
RNA extraction and analysis
Total RNA was extracted as described previously (Aiba et al.,
1981). Primer extension analysis was performed to identify
the transcriptional start of ORF2. RNA (70mg) was annealed
with Cy5-labelled primer PER (Table 1) at 42 1C overnight.
The annealed mixture was subjected to primer extension with
20 U of AMV Reverse Transcriptase (Promega) at 42 1C
for 2 h. The primer extension products were sequenced using
the ALFexpress Automated DNA Sequencer (Pharmacia
Biotech) and analysed together with the sequence products
using the same primer PER. For transcriptional analysis of
BF638R3281, total RNA was extracted from mid-logarithmic
phase cultures of B. fragilis 638R exposed to a sublethal dose
(1mg mL1) of metronidazole. Equal amounts of RNA (4mL
each, containing 10mg of RNA per spot) were spotted
onto nylon membranes and UV cross-linked (Hoefer UVC
Cross-linker, Amersham Biosciences). The DNA probe used
was an internal fragment of BF638R3281 obtained by PCR
using primer pair 2 (Table 2) and digoxigenin-labelled
using Digoxigenin (Roche Diagnostics). Hybridization
was performed overnight at 50 1C using EasyHyb hybridiza-
tion buffer and chemiluminescence detected using CSPD
(Roche Diagnostics).
Construction and characterization of a B. fragilis
BF638R3281 mutant
An internal fragment of BF638R3281 was amplified by PCR
from B. fragilis 638R, using primer pair 2 (Table 2). The
Table 2. Oligonucleotide primers
Pair Name Sequence (50–30) Purpose Origin
PER CY5GTC GTA CAA TTC ATC TGC Primer extension This study
1 Re1 CCT TAG CTG AAT AGT CCG PCR of full length ORF1 This study
Re2 CCT ATT GCA ATT GGC AGC
2 Re3 GGT TGT GGA AGA TCT CTT CC PCR of full length ORF2 This study
Re4 CAA GAT TAC GGT TGC AGC This study
2 AI1 ACA AAA CCC AGG AAG AAA CTC C To obtain internal fragment from 638RBF3281 This study
AI2 GCA GCG TAA AAA GAC TGA CGG This study
3 Re3 As above To confirm insertional mutation of 638RBF3281 This study
M13R GTT TTC CCA GTC ACG AC Yanisch-Perron et al. (1985)
4 Re4 As above To confirm insertional mutation of 638RBF3281 This study
M13F CGC CAG GGT TTT CCC AGT CAC GAC Yanisch-Perron et al. (1985)
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Fig. 1. Genomic organization of pAN2 and de-
letion plasmids. MTC and metronidazole (MTZ)
resistance phenotypes in both Escherichia coli
AB1886 (uvrA) and AB1885 (uvrB) are indicated:
1, increased resistance as compared with
E. coli transformed with control plasmid
pMT104;  , same level of sensitivity as
with pMT104.
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fragment was cloned into suicide vector pGERM (Cheng
et al., 2000) to create plasmid pGAR, which was transformed
into E. coli S17-1 and transferred via aerobic mating into
B. fragilis 638R as described previously (Hooper et al., 1999).
Putative mutants were selected anaerobically on BHIS agar
containing gentamycin 200mg mL1) and erythromycin
(10mg mL1). The mutation locus was confirmed by PCR
using primer pairs 3 and 4 (Table 2) to obtain fragments of
DNA flanking the plasmid insertion in BF638R3281. The
identity of the PCR fragments obtained was verified by
sequencing. The mutant was named B. fragilis 638R reg.
Analysis of growth of B. fragilis strains 638R and
B. fragilis 638R reg mutant
The growth of the wild-type and mutant strains in BHIS
broth was monitored. The OD600 nm of the cultures was
measured every 2 h for a period of 24 h (Spectrawave S1000,
Biochrom). Four independent experiments were performed
for each strain.
Sensitivity assays with DNA-damaging agents
Metronidazole (5mg mL1) was added to mid-logarithmic
cultures of the B. fragilis 638R and B. fragilis 638R reg
mutant. Aliquots were removed from cultures at times from
0 to 40 min. Viable cell numbers were determined under
anaerobic conditions by diluting aliquots in anaerobic water,
plating on BHIS agar and enumeration of colonies after two
days of growth at 37 1C. Survival after 40 min of exposure
was expressed relative to survival at 0 min of exposure.
For MTC assays, overnight cultures were centrifuged, and
cells were resuspended in prereduced Ringers solution to
obtain an OD600 nm of 0.8. MTC was added to a final
concentration of 1 mg mL1. Aliquots were removed from
cultures at times from 0 to 30 min. Dilutions of aliquots
were made and plated on BHIS agar to obtain viable cell
numbers. For both damaging agents, three independent
experiments were performed and the mean percentage
survival was calculated (SE in parentheses).
Results and discussion
Identification of a gene involved in
metronidazole and MTC resistance
A B. fragilis Bf-1 gene library was screened for genes
conferring increased metronidazole and MTC resistance in
E. coli uvr repair mutants. Escherichia coli AB1886 uvrA
transformants with increased MTC resistance relative to the
parent strain were isolated on plates containing 0.6 mg mL1
MTC. These were all found to harbour the same plasmid,
carrying a 4.5-kb DNA fragment from the B. fragilis
chromosome. The recombinant plasmid was designated
pAN2 (Fig. 1).
The presence of pAN2 also increased the survival of the
E. coli uvrA mutant following metronidazole treatment.
Similarly, the uvrB mutant containing pAN2 survived better
than the control after metronidazole and MTC exposure.
pAN2 did not affect the E. coli uvrC mutant survival
following either treatment (Table 3). The improved survival
conferred by pAN2 on E. coli uvrA and uvrB mutants after
metronidazole exposure was also present under anaerobic
conditions. The fact that the increased survival of metroni-
dazole-treated cells was seen under both aerobic and anae-
robic conditions suggested that the cloned gene product
might be linked to cell survival following DNA damage
caused by the activated metronidazole nitro radicals formed
under anaerobic conditions, as well as the reactive oxygen
species (ROS) formed during oxidation of metronidazole in
the presence of O2 (Edwards, 1977). This might also indicate
that the B. fragilis ORF2 is involved in a general stress
tolerance mechanism in the heterologous E. coli.
Deletion analysis of the 4.5-kb insert showed that only the
plasmids pANBB and pE2Reg (Fig. 1) yielded increased
resistance to the E. coli uvrA and uvrB mutants. This










AB1886 (pAN2) uvrA 0.7 400 50
AB1886 (pMT104) uvrA 0.5 300 35
AB1885 (pAN2) uvrB 1.1 950 250
AB1885 (pMT104) uvrB 0.7 600 220
AB1884 (pAN2) uvrC 0.7 300 ND
AB1884 (pMT104) uvrC 0.7 300 ND
A representative set of data is shown from 10 experiments.
The MIC was determined on LB agar plates under aerobic conditions.
wThe MICs were determined under aerobic conditions (O2) or anaerobic conditions in prereduced media (AnO2).
ND, not determined.
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suggested that the gene involved in the resistance phenotype
was found within the common region on these fragments.
The DNA insert in plasmid pAN2 that conferred resistance
to MTC and metronidazole was fully sequenced in both
directions. This region contained an incomplete ORF1,
truncated at the C-terminus, and two complete ORFs
(ORF2 and ORF3) (Fig. 1). Disruption of ORF2 by deletion
analysis caused loss of activity, suggesting the involvement
of the ORF2 gene product in resistance. This was confirmed
by the fact that the PCR-cloned full-length ORF2
alone caused the improved survival phenotype in E. coli
uvrA and uvrB mutants (data not shown). This gene was
designated reg.
Sequence analysis and primer extension of reg
The transcription start point of reg was determined using
primer extension analysis. A single primer extension pro-
duct identified the transcriptional start site to be an adenine
59 bp upstream of the putative ATG start codon of reg (Fig. 2).
The promoter region revealed the presence of sequences
similar to the B. fragilis promoter consensus sequences
(Bayley et al., 2000)  7 (TGAAATTTG) and  33 (GTTG).
Three sets of inverted repeats were identified in the promo-
ter region. One set was found upstream of the  33
promoter sequence, while the others were located near the
 33 and  7 promoter regions, which may involve a
regulatory role. The reg gene encoded a putative protein of
154 amino acids with a deduced molecular weight of
18.1 kDa and sequence similarity at the amino acid level to
members of the AraC/XylS family of transcriptional regula-
tors. AraC/XylS regulators typically contain a highly con-
served region of 100 amino acid residues that constitutes the
DNA-binding domain (Gallegos et al., 1997; Rhee et al.,
1998), and the B. fragilis Reg contained most of the amino
acids of this consensus sequence. The homologues of reg in
other B. fragilis strains are BF3248 in B. fragilis NCTC 9343
(Accession number NC_003228) and BF638R3281 in
B. fragilis 638R (www.sanger.ac.uk), and all three genes are
identical in nucleotide sequence and gene arrangement on
the chromosome.
The identification of a regulator from this family with
potential involvement in DNA repair is significant because a
number of these transcriptional regulators have been in-
volved in bacterial virulence (Frota et al., 2004), multidrug
resistance systems and in response to alkylating agents
(Tanaka et al., 1997). The best-characterized members of
this family are the E. coli MarA and Rob proteins, both of
which have been implicated in multidrug resistance (Galle-
gos et al., 1997; Kwon et al., 2000). The DNA-binding
regulatory domain of these two proteins contains seven
a-helices that have been shown to form two helix–turn–he-
lix (HTH) motifs involved in binding to adjacent grooves of
the DNA (Bustos & Schleif, 1993). The deduced amino acid
sequence of the B. fragilis Reg putative protein similarly
contained eight a-helices: one outside the conserved domain
and seven within the DNA-binding domain, with two
putative HTH motifs.
Mutation of the BF3248 homologue in B. fragilis
638R
In order to investigate the involvement of the putative
regulator in cell survival following DNA damage in
B. fragilis, a mutation in BF638R3281 (the BF3248 homo-
logue in strain 638R) was achieved by gene-specific inser-
tional inactivation. The B. fragilis Bf-1 strain could not be
used for this purpose because it cannot be genetically
manipulated. The site of insertion was confirmed by PCR
analysis of the insertion junction using M13 primers (an-
nealing to the inserted plasmid) in combination with B.
fragilis-specific primers flanking the mutated gene. The PCR
products obtained were sequenced, and this confirmed the
insertion of plasmid pGAR into the target gene. Sequence
data also revealed that the internal gene fragment, cloned
into the suicide vector to facilitate homologous recombina-
tion, was now duplicated and flanked the inserted plasmid.
The mutant was named B. fragilis 638R reg.
Growth analysis
The growth of B. fragilis 638R and B. fragilis 638R reg
in BHIS broth (Fig. 3) showed that the mutant grew
1    TAAAAGTTAAATATTCTTATTAACGGCCCTTTTTACCTACTTTTCGACGATTTTGATTGT
-33 –7         
61    TTTTATATCAAAAATATATACGAAAAAGTTGTGTATATCAAAATAATGTATGAAATTTGT
+1
121    GACATCTAAAGTTACAAATTAATAGTGATATTTAAAAACAAACCCTAACCAGTTAATTCA
181    ATGAGTGATTTAGAAAACAAAACCCAGGAAGAAACTCCTAAAAAACGCCCTTACAATTTA
241    AGGGAGAAAAAAGAAAAGAAAGCTGCTTACCGGTCTTTGATCAGACCCGAATTGGCAGAT
301    GAATTGTACGACAGAATCCTGAACATCATTGTTGTACAGAAGAAGTACAGAGACCCGGAC
Fig. 2. Identification of the Bacteroides fragilis
reg transcriptional start site by primer extension
analysis. Nucleotide sequence of the putative
promoter region of reg: the ATG start codon
(box) is at position 181, the transcription start
site is at (11) and the putative 7 and 33
motifs are in bold and underlined. The three
sets of inverted repeats are shown by matching
arrows. The reverse primer used is shown in
bold italics.
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more slowly than the parent strain, as measured by
OD600 nm. This was most noticeable at the later growth
stages, and after 24 h the parent and mutant showed
OD600 nm values of 1.048 ( 0.031) and 0.863 ( 0.014),
respectively. This suggested that the Reg protein is required
throughout growth, but might become more important
as the age of the culture increases. If Reg is a global regulator,
a number of essential cell functions could be affected by
its absence. However, it is interesting to note that a
slow growth phenotype has been described in certain
clinically isolated metronidazole-resistant B. fragilis isolates
(Gal & Brazier, 2004). It was, therefore, important to
determine whether the reg gene was itself regulated at the
transcription level by exposure to sublethal concentrations
of metronidazole, and whether the B. fragilis 638R reg
mutant was more or less sensitive to metronidazole that the
parent strain.
Regulation of reg transcription by exposure to
metronidazole
Transcription of the reg gene in B. fragilis 638R was analysed
during normal growth and after exposure to a sublethal dose
of metronidazole (1mg mL1). There was no change in the
level of transcription of this gene upon exposure to metro-
nidazole relative to the untreated control (data not shown).
This indicated that the putative regulator was expressed
constitutively under both these conditions.
Sensitivity to metronidazole and MTC
The B. fragilis 638R reg mutant was more sensitive than the
parent strain to both metronidazole and MTC, suggesting
that the gene product is involved in protecting the cells
against these DNA-damaging agents. This confirmed the
results obtained when the cloned gene was introduced into
the E. coli repair mutants. After 40 min of exposure of mid
logarithmic phase cultures to metronidazole, 91.38
( 18.5)% of B. fragilis 638R parent cells remained viable,
compared with only 8.5 ( 4.2)% of the reg mutant strain.
A similar pattern was observed on exposure to MTC, where
only 0.009 ( 0.063)% of the mutant cells survived expo-
sure to MTC, compared with 7.62 ( 2.75)% of the
B. fragilis 638R parent strain. These results suggest that reg
may perhaps be involved in modulating cell responses that
repair single-stranded breaks (caused by metronidazole)
and cross-linked DNA (caused by MTC).
DNA single- and double-strand breaks are repaired in
Gram-negative bacteria via the RecFOR and RecBCD path-
ways, respectively, through the helicase and exonuclease
functions of the proteins involved. Mutations in these path-
ways cause increased sensitivity of E. coli to DNA-damaging
agents such as MTC (Keller et al., 2001). Sensitivity to MTC
in Gram-negative bacteria is caused by mutations in recA,
defective nucleotide excision repair, as well as defective
recBCD and recFOR repair pathways (Keller et al., 2001;
Zuniga-Castillo et al., 2004). No information has been
published to date regarding the sensitivity of B. fragilis
recBCD mutants or recFOR mutants to metronidazole. This
report, therefore, describes a novel role for a putative AraC/
XylS transcriptional regulator with regard to the damage
induced by the DNA-damaging agents, metronidazole and
MTC. Further studies will elucidate which genes are regu-
lated by the Reg protein, and whether they are damage
specific or linked to general cell stress responses. The work
will provide valuable information concerning the ways in
which B. fragilis manages the DNA damage caused by
metronidazole and MTC exposure.
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